Editorials |
From the Unit of Pharmacology and Therapeutics, Department of Medicine, University of Louvain Medical School, Brussels, Belgium.
Correspondence to J.-L. Balligand, Unit of Pharmacology and Therapeutics, FATH 5349, Department of Medicine, University of Louvain Medical School, 53, Ave E Mounier, 1200 Brussels, Belgium. E-mail Balligand@ mint.ucl.ac.be
Key Words: nitric oxide caveolin heat shock protein 90 endothelium
Endothelial nitric oxide synthase (eNOS) produces NO (and/or other reactive nitrogen species) in vascular endothelial cells and cardiomyocytes in response to a variety of agonists and mechanical stimuli (eg, stretch, shear). The central role of NO in the homeostatic balance of the healthy endothelium justifies a growing interest in the molecular mechanisms governing its production by eNOS in a stimulus- and (sub)cellular-specific fashion, including in response to a variety of drugs (eg, statins, angiotensin-converting enzyme inhibitors, ß-blockers) widely used for the treatment of cardiovascular diseases. In addition to transcriptional regulation, eNOS activity is regulated posttranslationally by the availability of its substrate, L-arginine, and cofactors (eg, tetrahydrobiopterin [BH4]), as well as protein-protein interactions with a number of partners that activate or inhibit the enzyme. Because new information on transient clustering of signaling molecules is likely to accumulate, especially with the use of functional proteomics,1 thereby potentially increasing the list of eNOS regulators, one may legitimately ask these fundamental questions: (1) how do these different proteins associate with each other in a discrete subcellular compartment and in what sequential order and (2) how important is their (often transient) association for the proper functioning of any signaling pathway, especially in intact cells or in vivo. The availability of convergent data on x-ray crystal structure of the eNOS oxygenase domain, together with results using site-directed mutagenesis (or gene deletion experiments, eg, for caveolin-1 and caveolin-3) on several of the putative eNOS partners, now provides at least some of the answers and motivates
This article has been cited by other articles:
![]() |
J.-L. Balligand, O. Feron, and C. Dessy eNOS Activation by Physical Forces: From Short-Term Regulation of Contraction to Chronic Remodeling of Cardiovascular Tissues Physiol Rev, April 1, 2009; 89(2): 481 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mohan, R. Konopinski, B. Yan, V. E. Centonze, and M. Natarajan High glucose-induced IKK-Hsp-90 interaction contributes to endothelial dysfunction Am J Physiol Cell Physiol, January 1, 2009; 296(1): C182 - C192. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Stebbins, J. P. Stice, C. M. Hart, F. N. Mbai, and A. A. Knowlton Effects of Dietary Decosahexaenoic Acid (DHA) on eNOS in Human Coronary Artery Endothelial Cells Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2008; 13(4): 261 - 268. [Abstract] [PDF] |
||||
![]() |
J. L. Aschner, S. L. Foster, M. Kaplowitz, Y. Zhang, H. Zeng, and C. D. Fike Heat shock protein 90 modulates endothelial nitric oxide synthase activity and vascular reactivity in the newborn piglet pulmonary circulation Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1515 - L1525. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Yang and X.-F. Ming Recent advances in understanding endothelial dysfunction in atherosclerosis. Clin. Med. Res., March 1, 2006; 4(1): 53 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Icking, S. Matt, N. Opitz, A. Wiesenthal, W. Muller-Esterl, and K. Schilling NOSTRIN functions as a homotrimeric adaptor protein facilitating internalization of eNOS J. Cell Sci., November 1, 2005; 118(21): 5059 - 5069. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Wei and Y. Xia Roles of 3-Phosphoinositide-dependent Kinase 1 in the Regulation of Endothelial Nitric-oxide Synthase Phosphorylation and Function by Heat Shock Protein 90 J. Biol. Chem., May 6, 2005; 280(18): 18081 - 18086. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Fike, J. L. Aschner, Y. Zhang, and M. R. Kaplowitz Impaired NO signaling in small pulmonary arteries of chronically hypoxic newborn piglets Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1244 - L1254. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.R. Uhrenholt, J. Schjerning, P.B. Hansen, R. Norregaard, B.L. Jensen, G.L. Sorensen, and O. Skott Rapid Inhibition of Vasoconstriction in Renal Afferent Arterioles by Aldosterone Circ. Res., December 12, 2003; 93(12): 1258 - 1266. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.B. Massion, O. Feron, C. Dessy, and J.-L. Balligand Nitric Oxide and Cardiac Function: Ten Years After, and Continuing Circ. Res., September 5, 2003; 93(5): 388 - 398. [Abstract] [Full Text] [PDF] |
||||
![]() |
P B Massion and J-L Balligand Modulation of cardiac contraction, relaxation and rate by the endothelial nitric oxide synthase (eNOS): lessons from genetically modified mice J. Physiol., January 1, 2003; 546(1): 63 - 75. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |